BLS Pharmaceuticals Ltd

NEW
FRA:PR80 (Australia)  
€ 0.58 +0.036 (+6.68%) Jul 13
26.22
P/B:
10.66
Market Cap:
€ 135.03M ($ 154.01M)
Enterprise V:
€ 133.67M ($ 152.47M)
Volume:
1.75K
Avg Vol (2M):
4.38K
Trade In:
Volume:
1.75K
Avg Vol (2M):
4.38K

BLS Pharmaceuticals Ltd (FRA:PR80) Dividend

BLS Pharmaceuticals Ltd (FRA:PR80) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -50.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:PR80 Dividend

Does BLS Pharmaceuticals Ltd (FRA:PR80) pay a dividend?

BLS Pharmaceuticals Ltd (FRA:PR80) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BLS Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BLS Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -50.1% over the past 3 years.

What are dividend-paying alternatives to BLS Pharmaceuticals Ltd?

For dividend-paying alternatives in BLS Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.